Stability of cefozopran hydrochloride in aqueous solutions
The influence of pH on the stability of cefozopran hydrochloride (CZH) was investigated in the pH range of 0.44-13.00. Six degradation products were identified with a hybrid ESI-Q-TOF mass spectrometer. The degradation of CZH as a result of hydrolysis was a pseudo-first-order reaction. As general acid-base hydrolysis of CZH was not occurred in the solutions of hydrochloric acid, sodium hydroxide, acetate, borate and phosphate buffers, kobs = kpH because specific acid-base catalysis was observed. Specific acid-base catalysis of CZH consisted of the following reactions: hydrolysis of CZH catalyzed by hydrogen ions (kH+), hydrolysis of dications (k1H2O), monocations (k2H2O) and zwitter ions (k3H2O) and hydrolysis of zwitter ions (k1OH-) and monoanions (k2OH-) of CZH catalyzed by hydroxide ions. The total rate of the reaction was equal to the sum of partial reactions: [Formula: see text]. CZH similarly like other fourth generation cephalosporin was most stable at slightly acidic and neutral pH and less stable in alkaline pH. The cleavage of the β-lactam ring resulting from a nucleophilic attack on the carbonyl carbon in the β-lactam moiety is the preferred degradation pathway of β-lactam antibiotics in aqueous solutions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
---|---|
Enthalten in: |
Drug development and industrial pharmacy - 42(2016), 4 vom: 23., Seite 572-7 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zalewski, Przemysław [VerfasserIn] |
---|
Links: |
---|
Themen: |
059QF0KO0R |
---|
Anmerkungen: |
Date Completed 13.12.2016 Date Revised 13.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.3109/03639045.2015.1054834 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM250007274 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM250007274 | ||
003 | DE-627 | ||
005 | 20231227125206.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3109/03639045.2015.1054834 |2 doi | |
028 | 5 | 2 | |a pubmed24n1223.xml |
035 | |a (DE-627)NLM250007274 | ||
035 | |a (NLM)26079426 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zalewski, Przemysław |e verfasserin |4 aut | |
245 | 1 | 0 | |a Stability of cefozopran hydrochloride in aqueous solutions |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.12.2016 | ||
500 | |a Date Revised 13.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The influence of pH on the stability of cefozopran hydrochloride (CZH) was investigated in the pH range of 0.44-13.00. Six degradation products were identified with a hybrid ESI-Q-TOF mass spectrometer. The degradation of CZH as a result of hydrolysis was a pseudo-first-order reaction. As general acid-base hydrolysis of CZH was not occurred in the solutions of hydrochloric acid, sodium hydroxide, acetate, borate and phosphate buffers, kobs = kpH because specific acid-base catalysis was observed. Specific acid-base catalysis of CZH consisted of the following reactions: hydrolysis of CZH catalyzed by hydrogen ions (kH+), hydrolysis of dications (k1H2O), monocations (k2H2O) and zwitter ions (k3H2O) and hydrolysis of zwitter ions (k1OH-) and monoanions (k2OH-) of CZH catalyzed by hydroxide ions. The total rate of the reaction was equal to the sum of partial reactions: [Formula: see text]. CZH similarly like other fourth generation cephalosporin was most stable at slightly acidic and neutral pH and less stable in alkaline pH. The cleavage of the β-lactam ring resulting from a nucleophilic attack on the carbonyl carbon in the β-lactam moiety is the preferred degradation pathway of β-lactam antibiotics in aqueous solutions | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Cefozopran hydrochloride | |
650 | 4 | |a HPLC | |
650 | 4 | |a Q-TOF | |
650 | 4 | |a degradation products | |
650 | 4 | |a stability in aqueous solutions | |
650 | 7 | |a Cephalosporins |2 NLM | |
650 | 7 | |a Pharmaceutical Solutions |2 NLM | |
650 | 7 | |a Water |2 NLM | |
650 | 7 | |a 059QF0KO0R |2 NLM | |
700 | 1 | |a Skibiński, Robert |e verfasserin |4 aut | |
700 | 1 | |a Paczkowska, Magdalena |e verfasserin |4 aut | |
700 | 1 | |a Garbacki, Piotr |e verfasserin |4 aut | |
700 | 1 | |a Talaczyńska, Alicja |e verfasserin |4 aut | |
700 | 1 | |a Cielecka-Piontek, Judyta |e verfasserin |4 aut | |
700 | 1 | |a Jelińska, Anna |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug development and industrial pharmacy |d 1994 |g 42(2016), 4 vom: 23., Seite 572-7 |w (DE-627)NLM077783093 |x 1520-5762 |7 nnns |
773 | 1 | 8 | |g volume:42 |g year:2016 |g number:4 |g day:23 |g pages:572-7 |
856 | 4 | 0 | |u http://dx.doi.org/10.3109/03639045.2015.1054834 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 42 |j 2016 |e 4 |b 23 |h 572-7 |